Clinical validation of the CD32b biomarker on the European market

Tak Mak

CRC Tier 1 - Determining why mutations of the metabolic enzyme isocitrate dehydrogenase cause leukemias and brain cancers

Leukaemia Brain, nervous system

Scott A Armstrong

Targeting to Epigenetic Modications in ALL

Leukaemia

Qing Lan

Studies of Myeloid Progenitor Cells and Hematotoxicity in Workers Exposed to Formaldehyde

Leukaemia

Hematology and hematologic malignancies

Derrick J. Rossi

Reprogramming committed blood cells to a hematopoietic stem cell fate

Leukaemia

Hematology and hematologic malignancies

Nya D Nelson

Elucidating the role of TIN2L at the telomere and in dyskeratosis congenita

Lip, oral cavity Leukaemia

Pathology

Rainer F Storb

Hematopoietic Chimerism after Stem Cell Allografts

Non-Hodgkin lymphoma Leukaemia

Hematology and hematologic malignancies Radiation Oncology

Peter Inskip

Cancer Risk in Chernobyl Clean-up Workers from Baltic Countries

Thyroid Leukaemia Brain, nervous system

Radiation Oncology

Gu Hua

MicroRNA regulation of normal and malignant hematopoietic stem cell biology

Leukaemia

Marina Y Konopleva

Hypoxia-Selective Kinase Inhibitors for Leukemia Therapy

Leukaemia

Hematology and hematologic malignancies Pathology